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Abstract 
Background: Insecticide‑based interventions have averted more than 500 million malaria cases since 2000, but 
insecticide resistance in mosquitoes could bring about a rebound in disease and mortality. This study investigated 
whether insecticide resistance was associated with increased incidence of clinical malaria.
Methods: In an area of southern Benin with insecticide resistance and high use of insecticide‑treated nets (ITNs), 
malaria morbidity and insecticide resistance were measured simultaneously in 30 clusters (villages or collections of vil‑
lages) multiple times over the course of 2 years. Insecticide resistance frequencies were measured using the standard 
World Health Organization bioassay test. Malaria morbidity was measured by cases recorded at health facilities both in 
the whole population using routinely collected data and in a passively followed cohort of children under 5 years old.
Results: There was no evidence that incidence of malaria from routinely collected data was higher in clusters with 
resistance frequencies above the median, either in children aged under 5 (RR = 1.27 (95% CI 0.81–2.00) p = 0.276) or 
in individuals aged 5 or over (RR = 1.74 (95% CI 0.91–3.34) p = 0.093). There was also no evidence that incidence was 
higher in clusters with resistance frequencies above the median in the passively followed cohort (RR = 1.11 (0.52–2.35) 
p = 0.777).
Conclusions: This study found no association between frequency of resistance and incidence of clinical malaria in 
an area where ITNs are the principal form of vector control. This may be because, as other studies have shown, ITNs 
continue to offer some protection from malaria even in the presence of insecticide resistance. Irrespective of resist‑
ance, nets provide only partial protection so the development of improved or supplementary vector control tools is 
required to reduce Africa’s unacceptably high malaria burden.
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Background
African malaria vector populations are becom-
ing increasingly resistant to the insecticides used for 
malaria prevention [1–3]. This is especially true for 
pyrethroids, the class of insecticide used on all insec-
ticidal bed nets. The growing inability of insecticides to 
kill malaria vectors is concerning because insecticide-
based interventions are vital to preventing death and 
disease from malaria in African children. Insecticide-
treated nets (ITNs) are estimated to be responsible for 
78% of the 663 million clinical malaria cases averted in 
sub-Saharan Africa since 2001, and more than 50% of 
people in malaria-endemic areas in sub-Saharan Africa 
slept under ITNs in 2016 [4, 5].
However, it is not clear how the rise of insecticide 
resistance will affect the malaria burden in Africa. 
Mathematical models predict increased malaria inci-
dence but real world evidence of this is lacking [6]. 
There are some data from malaria control programmes 
in South Africa, Equatorial Guinea and Sudan that sug-
gest an impact of resistance on the malaria burden, but 
these examples relate to indoor residual spraying (IRS) 
of insecticides rather than ITNs, and in none of the 
cases is the evidence conclusive [7–11].
There have been no convincing examples of ITN 
malaria control failure due to pyrethroid resistance. 
Two recent trials have shown that in an areas of resist-
ance, nets that either incorporated the synergist piper-
onyl butoxide (PBO) or another active ingredient in 
addition to a pyrethoid were more effective than con-
ventional ITNs [12, 13]. Although the trials did not 
attempt to assess whether standard ITNs provide pro-
tection in an area of pyrethroid resistance, they did 
show that their effectiveness was inferior to that of 
the modified nets in these settings. It will take time to 
roll out a new class of nets in all areas with a similar 
resistance profile and in the meantime the question of 
whether conventional ITNs continue to provide suffi-
cient protection from malaria is a pressing one.
The current study is part of a programme designed to 
address the impacts of insecticide resistance [14, 15]. 
Results published so far demonstrate that children who 
sleep under ITNs are at lower risk of malaria infection 
as measured by cross-sectional surveys, and that chil-
dren who sleep under ITNs experience a lower rate of 
clinical malaria episodes as measured by active follow 
up [11, 16–18]. The present study assessed the impact 
of insecticide resistance at the community level on clin-
ical malaria episodes severe enough to prompt a visit to 
a health facility for treatment. Specifically, the aim is to 
answer the question of whether higher frequencies of 
resistance to pyrethroids are associated with a greater 
rate of clinical malaria in an area where ITNs are the 
main form of vector control.
Methods
To answer the study question, insecticide resistance and 
incidence of clinical malaria were measured concur-
rently in 30 clusters in two consecutive years to test for 
associations.
Study setting
The study was conducted in the Plateau Department of 
Benin. Observations were made in 30 clusters (villages 
or collections of villages) in four rural districts: Ifangni, 
Sakete, Ketou, and Pobe. The area of the study region is 
3264 sq km, with an approximate population of 400,000. 
The estimated populations of the study clusters ranged 
from 961 to 7496 with a median of 2132. There are two 
rainy seasons, one from April to July and a second from 
September to October. The principal vectors of malaria 
across the area are  Anopheles gambiae  sensu stricto 
and  Anopheles coluzzii [19]. In West Africa, there is 
extensive introgression of resistance mutations between 
the two species [20, 21]. In Benin, levels of resistance in 
the two species were found to be similar [20], and as such 
the two species are treated as a single entity for the pur-
pose of this study. ITNs are the main form of vector con-
trol in the area. The national malaria control programme 
distributed ITNs (a mixture of  PermaNet®  2.0 (Vest-
ergaard),  Olyset® Net (Sumitomo), and  DawaPlus®  2.0 
(Tana Netting)) in 2011 and 2014. In 2015, 78% of chil-
dren under 5 were reported to have used an ITN the pre-
vious night [16].
Entomological measurements
Mosquito larvae were collected from aquatic habitats in 
each cluster and were reared to adults to assess suscep-
tibility to pyrethroids. Sampling took place three times 
during the study: June 2013, October 2013 and July 2014. 
Larvae were reared until they were 2–5 days-old adults. 
Female mosquitoes were exposed to the discriminating 
dose of deltamethrin (0.05%) using the standard World 
Health Organization (WHO) bioassay test [22] at a rela-
tive humidity of 80 ± 10% and a temperature of 25 ± 2 °C 
mosquito mortality was recorded 24 h after deltamethrin 
exposure.
Malaria morbidity measurements
Estimates of cluster level malaria morbidity came from 
two independent sources. First, registers of patients 
routinely kept at health facilities for 2013 were exam-
ined. Data on the number of malaria cases with axil-
lary temperature above 37.5  °C and confirmed by either 
microscopy or rapid diagnostic test were recorded from 
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health facilities in the study area. The registers contained 
information about where each case lived so it was pos-
sible to determine whether the case came from one of the 
study clusters. It was also recorded whether the case was 
aged under 5. Estimates for the population of each clus-
ter taken from a census in 2012 were used to calculate 
the person-time at risk of clinical malaria in each clus-
ter. Second, at the beginning of 2013, 70 children aged 
under 5 in each cluster were recruited into a cohort. Each 
child was given a card entitling them to free health care 
at the local health facility. Each visit to a health facility 
by a child carrying a study card was recorded. The record 
included information on the result of any malaria diagno-
sis by rapid diagnostic test (RDT) or microscopy. Follow 
up was from January 2013 to December 2014.
Sample size
For the routine health facility data, 30 clusters with 
median size of 380 children under 5 per cluster observed 
for 1 year would give 93% power to detect a difference in 
the rate of clinical malaria between the 15 highest resist-
ance clusters and the 15 lowest resistance clusters if there 
is a rate of 0.2 cases per child year in the highest resist-
ance clusters and a 33% lower rate of 0.13 cases per child 
year in the lowest resistance clusters, assuming a coeffi-
cient of between cluster variation of 0.25.
For the passively followed cohort, 30 clusters with 70 
children per cluster followed for 2 years would give 90% 
power to detect a difference in the rate of clinical malaria 
between the 15 highest resistance clusters and the 15 
lowest resistance clusters if there is a rate of 0.2 cases per 
child year in the highest resistance clusters and a 33% 
lower rate of 0.13 cases per child year in the lowest resist-
ance clusters, assuming a coefficient of between-cluster 
variation of 0.25.
Statistical analysis
Although mosquito mortality was measured at three time 
points in the study period, child follow up was continu-
ous. To account for this, child follow-up time was divided 
into three periods and each period was matched to one 
of the three measurements of mosquito mortality. Fol-
low up from January to July 2013 was matched with the 
mosquito mortalities in June 2013; August to December 
2013 was matched with the mosquito mortality measure-
ments taken in October 2013; and (for the passively fol-
lowed cohort) January to December 2014 was matched 
with the mosquito mortality measurements taken in 
July 2014. During each study period clusters were clas-
sified as higher resistance or lower resistance accord-
ing to whether mosquito mortality was below or above 
the median, respectively. Analyses were performed both 
separately in each time period and for the total combined 
follow up (for the combined follow up, higher resistance 
was defined in terms of the median of all measurements). 
For the routine health centre data, analyses were per-
formed separately for children aged under 5 and for peo-
ple aged 5 or over.
In each time period, malaria incidence was estimated 
as the number of incident cases per child-year of follow 
up. In the passively followed cohort, a 2-week period 
was subtracted from the time at risk to account for the 
prophylactic effect of the treatment. Incidence was cal-
culated overall and separately for higher and lower resist-
ance clusters.
Poisson regression was used to estimate the incidence 
rate ratio (RR) between higher and lower resistance clus-
ters. Poisson regression was also used to estimate the 
linear effect of a reduction in mosquito mortality on 
cluster-level clinical malaria incidence. Robust standard 
errors were used to account for correlation of responses 
within clusters.
For the passively followed cohort there were a small 
number of highly influential outlying observations. Anal-
yses were repeated omitting clusters where the rate was 
rate greater than 2 standard deviations above the mean 
cluster-level rate.
Results
Insecticide resistance
Insecticide resistance was evaluated in all 30 clusters 
over the 2  years of the study: (n = 26 June 2013, n = 27 
October 2013, n = 26 July 2014). Twenty-one clusters 
had resistance measured at all three time points. A total 
of 7388 mosquitoes were tested for resistance: 1975 in 
June 2013 (median of 77 per cluster); 2955 in October 
2013 (median of 109 per cluster); and, 2458 in July 2014 
(median of 94 per cluster).
Median cluster level mortality following deltamethrin 
exposure was 95.3% in June 2013, 93.9% in October 2013 
and 47.3% in July 2014 (Fig. 1). Of the 79 mortality obser-
vations, 13 (16%) were above 98% mortality (suscepti-
ble using the WHO classification (22)), 31 (39%) were 
between 98 and 90% mortality (possible resistance), and 
35 (44%) were below 90% mortality (confirmed resist-
ance) (Fig. 1).
Health facility data
For children under 5 there were 3108 confirmed cases of 
malaria in 2013 at a rate of 0.24 cases per child-year (95% 
CI 0.18–0.32) (Table 1). There was no evidence that the 
rate was higher in higher resistance clusters in 2013 as a 
whole (RR = 1.27 (95% CI 0.81–2.00) p = 0.276) nor was 
there evidence of higher incidence in higher resistance 
clusters either in January to July (RR = 1.33 (95% CI 0.70–
2.52) p = 0.368) or in August to December (RR = 1.12 
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(95% CI 0.63–2.02) p = 0.684). There was no evidence of a 
linear association at either time period (Fig. 2).
For those aged 5 or over, there were 1894 confirmed 
cases of malaria in 2013 at a rate of 0.026 cases per per-
son year (95% CI 0.017–0.039) (Table 1). Similarly as for 
under 5 s, there was no evidence that the incidence rate 
was higher in higher resistance clusters over the whole of 
2013 (RR = 1.74 (95% CI 0.91–3.34) p = 0.093). There was 
also no evidence of higher incidence in higher resistance 
clusters either in January to July (RR = 1.77 (95% CI 0.88–
3.56) p = 0.102) or in August to December (RR = 1.60 
(95% CI 0.69–3.68) p = 0.261). There was no evidence of a 
linear association in either time period (Fig. 3).
Passively followed cohort
There were 784 confirmed clinical malaria cases in the 
2 years of follow up at a rate of 0.22 cases per child year 
Fig. 1 Cluster level malaria mosquito mortality on exposure to 
deltamethrin. The red dotted lines represent 98% mortality (possible 
resistance) and 90% mortality (confirmed resistance)
Table 1 Rates of clinical malaria from routine health facility data
Under 5 years of age 5 years of age or over
Malaria incidence 
per person-year (95% CI) 
[cases/person-years]
Rate ratio (95% CI) Malaria incidence 
per person-year (95% CI) 
[cases/person-years]
Rate ratio (95% CI)
January–July 2013
Overall 0.20 (0.15–0.26) [1545/7832] – 0.023 (0.016–0.034) 
[1015/43,510]
–
Lower resistance (mortality 
equal to or above median 
value of 95.3%)
0.18 (0.11–0.30) [635/3443] 1 0.016 (0.010–0.028) 
[311/19,126]
1
Higher resistance (mortal‑
ity below median value of 
95.3%)
0.21 (0.14–0.31) [910/4389] 1.12 (0.63–2.02)
p = 0.684
0.029 (0.017–0.049) 
[704/24,385]
1.77 (0.88–3.56)
p = 0.102
Effect per 10% reduction in 
bioassay mortality
– 1.02 (0.80–1.29)
p = 0.863
– 1.06 (0.85–1.32)
p = 0.605
August–December 2013
Overall 0.30 (0.21–0.42) [1563/5211] – 0.030 (0.019–0.049) 
[879/28,948]
–
Lower resistance (mortality 
equal to or above median 
value of 93.9%)
0.26 (0.19–0.35) [728/2798] 1 0.024 (0.017–0.033) 
[370/15,545]
1
Higher resistance (mortal‑
ity below median value of 
93.9%)
0.35 (0.19–0.64) [835/2413] 1.33 (0.70–2.52)
p = 0.368
0.038 (0.017–0.087) 
[509/13,403]
1.60 (0.69–3.68)
p = 0.261
Effect per 10% reduction in 
bioassay mortality
– 0.94 (0.50–1.77)
p = 0.854
– 0.89 (0.43–1.81)
p = 0.731
January–December 2013 (both time periods combined)
Overall 0.24 (0.18–0.32) [3108/13,044] – 0.026 (0.017–0.039) 
[1894/72,458]
–
Lower resistance (mortality 
equal to or above median 
value of 93.9%)
0.21 (0.16–0.28) [1376/6472] 1 0.019 (0.014–0.026) 
[693/35,952]
1
Higher resistance (mortal‑
ity below median value of 
94.8%)
0.26 (0.17–0.41) [1732/6572] 1.27 (0.81–2.00) p = 0.276 0.033 (0.018–0.060) 
[1201/36,506]
1.74 (0.91–3.34) p = 0.093
Effect per 10% reduction in 
bioassay mortality
– 1.01 (0.82–1.25) p = 0.915 – 1.04 (0.86–1.26) p = 0.677
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Fig. 2 Cluster level malaria mosquito mortality on exposure to deltamethrin versus rate of clinical malaria in children under 5 taken from health 
facility data from January to July 2013 (left) and August to December 2013 (right). Red lines represent lines of best fit
Fig. 3 Cluster level malaria mosquito mortality on exposure to deltamethrin versus rate of clinical malaria in individuals aged 5 or over taken from 
health facility data from January to July 2013 (left) and August to December 2013 (right). Red lines represent lines of best fit
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(95% CI 0.14–0.34) (Table  2). There was no evidence 
that the rate of clinical malaria was higher in clusters 
with higher resistance (RR = 1.11 (95% CI 0.52–2.35) 
p = 0.777). There was evidence that there was higher 
incidence in higher resistance clusters in January to July 
2013 (RR = 3.45 (95% CI 1.17–10.20) p = 0.027) and Janu-
ary to December 2014 (RR = 3.93 (95% CI 1.34–11.51) 
p = 0.015). However, when outlying clusters with rates 
greater than 2 standard deviations above the mean clus-
ter-level rate were removed (1 in January to July 2013 
and 2 in January to December 2014) the effects were no 
longer significant (Fig. 4).
Whilst there was evidence of a linear association 
between increasing resistance and clinical incidence 
during the 2  years of follow up RR = 1.50 for a 10% 
decrease of mosquito mortality (95% CI 1.14–1.97, 
p = 0.005) when outlying clusters with rates greater than 
2 standard deviations above the mean cluster-level rate 
were removed, the association was no longer significant 
RR = 1.17 (95% CI 0.90–1.53, p = 0.239).
Discussion
This study found no evidence of an association between 
vector resistance and incidence of clinical malaria meas-
ured by routine health facility data in an area where ITNs 
were the principal form of malaria control. This was true 
for children aged under 5 and for those aged over 5. There 
was some evidence that incidence of clinical malaria in 
a passively followed cohort was higher in higher resist-
ance, but this evidence was not robust and was the result 
of a small number of outlying clusters; once these clusters 
were removed, there was no evidence of an association.
This study is in line with the results of the same net-
work of studies on the impact of insecticide resistance 
Table 2 Rates of clinical malaria from a passively followed cohort of children under 5 years of age
a  Defined as cluster level rate greater than 2 standard deviations above the mean cluster-level rate
Malaria incidence per person-
year (95% CI) [cases/person-
years]
Rate ratio (95% CI) Rate ratio 
excluding  outliersa 
(95% CI)
January–July 2013
Overall incidence 0.12 (0.06–0.22) [124/1057] – –
Lower resistance (mortality equal to or above median value of 
95.3%)
0.05 (0.02–0.13) [28/530] 1 1
Higher resistance (mortality below median value of 95.3%) 0.18 (0.09–0.39) [96/527] 3.45 (1.17–10.20)
p = 0.027
2.48 (0.88–7.00)
p = 0.082
Effect per 10% reduction in bioassay mortality – 1.46 (0.84–2.54)
p = 0.170
1.11 (0.68–1.82)
p = 0.667
August–December 2013
Overall incidence 0.31 (0.19–0.49) [240/778] – –
Lower resistance (mortality equal to or above median value of 
93.9%)
0.42 (0.22–0.80) [158/373] 1 1
Higher resistance (mortality below median value of 93.9%) 0.20 (0.11–0.39) [82/405] 0.48 (0.21–1.11)
p = 0.083
0.60 (0.26–1.37)
p = 0.214
Effect per 10% reduction in bioassay mortality – 0.45 (0.16–1.33)
p = 0.143
0.46 (0.14–1.58)
p = 0.208
January–December 2014
Overall incidence 0.23 (0.13–0.41) [420/1804] – –
Lower resistance (mortality equal to or above median value of 
47.2%)
0.09 (0.04–0.25) [86/907] 1 1
Higher resistance (mortality below median value of 47.2%) 0.37 (0.20–0.70) [334/897] 3.93 (1.34–11.51) p = 0.015 2.46 (0.89–6.78)
p = 0.080
Effect per 10% reduction in bioassay mortality – 1.61 (1.21–2.13) p = 0.002 1.28 (0.91–1.79)
p = 0.144
January 2013–December 2014 (all time periods combined)
Overall incidence 0.22 (0.14–0.34) [784/3639] – –
Lower resistance (mortality equal to or above median value of 
47.2%)
0.20 (0.13–0.31) [270/1378] 1 1
Higher resistance (mortality below median value of 91.3%) 0.23 (0.13–0.40) [514/2261] 1.11 (0.52–2.35)
p = 0.777
0.89 (0.42–1.86)
p = 0.738
Effect per 10% reduction in bioassay mortality – 1.50 (1.14–1.97)
p = 0.005
1.17 (0.90–1.53)
p = 0.239
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which have reported on less severe outcomes than this 
study [11, 16–18]. All other studies in the network, as 
well as other studies [23], indicate that ITNs continue to 
provide protection with no association found between 
resistance and malaria outcomes including malaria prev-
alence, infection incidence, and actively detected clinical 
malaria incidence. Therefore, this study is consistent with 
previous findings that looked at less severe outcomes.
Why might there be no association between vector 
resistance and incidence of clinical malaria in an area 
where ITNs are the principal method of vector control? 
Firstly, even without insecticide, nets are a physical bar-
rier between the sleeper and the mosquito. Secondly, 
resistance is not an all-or-nothing phenomenon; even if 
the proportion of mosquitoes killed within 24 h of expo-
sure is reduced, the insecticide may still have an impact. 
For example, a meta-analysis found that ITNs gave 
greater protection than untreated nets [24], even in areas 
where mosquitoes were resistant to pyrethroids. There 
may also be more subtle effects in play. Oocyst devel-
opment may be slower in resistant mosquitoes exposed 
to a pyrethroid compared to those that have not been 
exposed [25], and there may be post-24-h mortality when 
pyrethroid-resistant malaria vectors are exposed to del-
tamethrin [26].
This study used two different methods to estimate the 
rate of clinical malaria severe enough to prompt a visit 
to a health facility. If the two methods gave very differ-
ent estimates it would have cast doubt on the validity 
of the study. Routine health records gave an estimate of 
0.22 cases per child year for children aged under 5 (95% 
CI 0.14–0.34) and the passive cohort gave a very similar 
estimate of 0.20 cases per child year for children aged 
under 5 (95% CI 0.13–0.30). An actively followed cohort 
in the same clusters gave an estimate of 0.48 cases per 
child year for children aged under 5 (95% CI 0.39–0.59). 
One would expect the rate to be higher in the actively fol-
lowed cohort because the follow up would detect cases 
of malaria that might not have been severe enough to 
prompt a visit to a health facility.
This study had several limitations. Firstly, there is no 
direct observation of ITNs providing protection. Instead, 
it must be inferred at the ecological level from the fact 
that even though ITNs are the primary form of malaria 
control in the study area, malaria incidence was not 
higher in villages where resistance was higher. The pas-
sive nature of the study meant that it was not possible 
to record ITN use and provide an estimate of the level 
of individual protection afforded by ITNs. Furthermore, 
aside from personal protection the ITNs may also pro-
vide protection through mass effect, whereby the killing 
of mosquitoes reduces local mosquito longevity and den-
sity and provides protection for all members of the com-
munity, including those who do not use ITNs. The study 
design used did not enable differentiation between these 
two types of protection.
A second limitation is that the range of insecticide 
measurements was small in 2013, with the majority of 
clusters between 90 and 98% mortality (defined by the 
WHO as possible resistance) with relatively few clus-
ters classified as harbouring vectors with confirmed 
resistance (< 90% mortality). Insecticide resistance 
measurement was based on the WHO insecticide suscep-
tibility test, measuring simply the frequency of resistant 
Fig. 4 Cluster level malaria mosquito mortality on exposure to 
deltamethrin versus rate of clinical malaria from a passively followed 
cohort of children under 5 years of age from January to July 2013 
(top), August to December 2013 (middle), and January to December 
2014 (bottom). Solid red lines represent lines of best fit; dashed red 
lines represent lines of best fit omitting outliers (these are the circled 
points defined as cluster level rate greater than 2 standard deviations 
above the mean cluster‑level rate)
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mosquitoes. Measures of resistance intensity based on a 
dose–response relationship which capture the intensity 
of resistance may been more informative, but were not 
practical for the scale of this study and the other associ-
ated studies [27].
Thirdly, in some clusters study staff were unable to find 
larvae at every time point so there are a small number of 
missing resistance measurements. This study made the 
assumption that mosquitoes collected at larval stage are 
representative of the population transmitting malaria at 
the adult stage. This is a reasonable assumption given 
that An. gambiae s.l. is the predominant anopheline col-
lected at both larval and adult stages and has been impli-
cated as the primary malaria vector in Plateau State [15].
Fourthly, randomization of locations to insecticide 
resistance is not possible. Therefore, any study on this 
issue must have an observational design, rendering it 
subject to confounding factors. The nature of this study 
meant it was not possible to record potential confound-
ing factors such as socio-economic status. Nevertheless, 
studies that did control for confounding factors found 
similar results to the current study for less severe malaria 
outcomes [16, 17].
Conclusion
This study did not find evidence for an association 
between insecticide resistance and malaria incidence 
in an area reliant on ITNs for malaria control. This is 
in accordance with the results of previous studies that 
looked at less severe malaria outcomes. Taken together 
with other studies in this programme, these results pro-
vide additional evidence that, even in the presence of 
insecticide resistance, populations living in malaria-
endemic areas are protected from malaria by pyrethroid-
only ITNs and, therefore, their use should continue. 
Nevertheless, new tools such as new generation nets that 
are not solely reliant on pyrethroids will be essential to 
sustain and further the gains made against malaria. In 
the interim, efforts should be made to increase access to 
good condition long-lasting insecticidal nets.
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